Artificial Retina Implant Market is predicted to reach USD 7.04 billion at a CAGR of 21.22% during the forecast period 2023-2032

Market Research Future (MRFR) has published on the “Global Artificial Retina Implant Market”.

The global artificial retina implant market is projected to register a CAGR of 21.22% during the forecast period of 2025 to 2032.

MRFR recognizes the following companies as the key players in the global artificial retina implant market Bionic Vision Technologies (US), PIXIUM VISION (France), Optobionics (US), Labtician Ophthalmics, Inc (Canada), Vivani Medical Inc. (US), iBIONICS (Canada), LambdaVision, Inc. (US), AXORUS (France), Sensor-Tech Lab (Russia), Nanovision (US), and among others.

Market Highlights

The global artificial retina implant market is accounted to register a CAGR of 21.22% during the forecast period and is estimated to reach USD 7.04 billion by 2032.

The global artificial retina implant market is growing significantly owing to the increasing incidences of retinitis pigmentosa and age-related macular degeneration (AMD), which are the major causes among the geriatric population. AMD affects millions of people across the globe, and current treatment options for AMD are limited in efficacy. Due to this, people are prompting to demand innovation solutions, which include artificial retina implants. Moreover, the market is further bolstered by increasing start-ups in order to innovate artificial retinal implants, bringing implant miniaturization, biocompatibility, electrode design, and wireless communication capabilities. However, one of the major challenges is the high cost associated with artificial retina implants, which is hindering the growth of the market. Moreover, increasing investment and funding are creating lucrative opportunities for the market. For instance, April 2020, LambdaVision, Inc. (US) received a USD 5 million award from the National Aeronautics and Space Administration for additional ISS research. This amount was utilized to continue to develop retinal implants. The implant is capable of restoring high-resolution vision to patients with retinal degeneration.

Access Full Report @ https://www.marketresearchfuture.com/reports/artificial-retina-implant-market-22219

Segment Analysis

The global artificial retina implant market has been segmented based product type and application

On the basis of product type, the global artificial retina implant market is segmented epiretinal implants, subretinal implants, and suprachoroidal implants. The suprachoroidal implants segment accounted for the largest market with a market share of 100% in 2025 due to its advantages such as Long-term IOP control without the need for daily management, a single, structurally sound implant, biocompatible, minimally invasive, and office-based surgery that is simple to implement in developing countries.

Based on application, the global artificial retina implant market is segmented into age-related macular degeneration (AMD) and retinitis pigmentosa. The age-related macular degeneration (AMD) segment accounted for the largest market in 2025 and is anticipated to be the fastest-growing for the forecast period of 2025–2032. This is because it is a progressive vision loss that significantly impacts the patient's ability to perform routine daily activities. The implant can restore vision, improve functional vision, and enhance quality of life.

Regional Analysis

The global artificial retina implant market, based on region, has been divided into North America, Europe, Asia-Pacific, and Rest of the World.

North America held the largest market share in terms of revenue in 2025 due to the rising incidence of AMD and presence of market players such as Bionic Vision Technologies (US), Optobionics (US), Vivani Medical Inc. (US), LambdaVision, Inc. (US), Nanovision (US), and among others. Further, these players are forming strategic alliances which is burgeoning the market growth. For instance, in August 2022, Second Sight Medical Products Inc. (US) announced the completion of its merger with Nano Precision Medical Inc. (US) and the name change to Vivani Medical, Inc. Such developments underscore the region’s role in fostering innovation and growth within the artificial retina implant market.

Moreover, Europe shows significant growth during the forecast period due to growing strategic alliances, especially investment to support artificial retina implant research and development. For instance, in October 2019, Axorus (France) develops a high-resolution artificial retina for patients suffering from AMD and retinitis pigmentosa. It had raised USD 91.8 million in its seed round funding.

Furthermore, the Asia-Pacific retina implant market is the fastest-growing and presents lucrative growth opportunities for the global market due to its huge patient pool, growing population, and growing geriatric population. Furthermore, increasing disposable income and rising awareness associated with the artificial retina implant market are burgeoning market growth.

The Rest of the World region is comprised of the Middle East, Africa, and Latin America. The artificial retina implant market in the rest of the world is experiencing significant growth due to various factors, including increasing investments in healthcare infrastructure and growing incidences of age-related macular degeneration (AMD).

Key Findings of the Study

• The global artificial retina implant market is expected to reach USD 7.04 billion by 2032, at a CAGR of 21.22% during the forecast period.


• The Europe region held the second largest market share of the global market in 2025 and is the fastest-growing region, owing to the increasing investment and funding associated with artificial retina implant.


• Bionic Vision Technologies (US), PIXIUM VISION (France), Optobionics (US), Labtician Ophthalmics, Inc (Canada), Vivani Medical Inc. (US), iBIONICS (Canada), LambdaVision, Inc. (US), AXORUS (France), Sensor-Tech Lab (Russia), Nanovision (US), and among others are the key players in the market.